Skip to main content
Top
Published in: AIDS and Behavior 2/2014

Open Access 01-02-2014 | Original Paper

Is Forced Migration a Barrier to Treatment Success? Similar HIV Treatment Outcomes Among Refugees and a Surrounding Host Community in Kuala Lumpur, Malaysia

Authors: Joshua B. Mendelsohn, Marian Schilperoord, Paul Spiegel, Susheela Balasundaram, Anuradha Radhakrishnan, Christopher K. C. Lee, Natasha Larke, Alison D. Grant, Egbert Sondorp, David A. Ross

Published in: AIDS and Behavior | Issue 2/2014

Login to get access

Abstract

In response to an absence of studies among refugees and host communities accessing highly active antiretroviral therapy (HAART) in urban settings, our objective was to compare adherence and virological outcomes among clients attending a public clinic in Kuala Lumpur, Malaysia. A cross-sectional survey was conducted among adult clients (≥18 years). Data sources included a structured questionnaire that measured self-reported adherence, a pharmacy-based measure of HAART prescription refills over the previous 24 months, and HIV viral loads. The primary outcome was unsuppressed viral load (≥40 copies/mL). Among a sample of 153 refugees and 148 host community clients, refugees were younger (median age 35 [interquartile range, IQR 31, 39] vs 40 years [IQR 35, 48], p < 0.001), more likely to be female (36 vs 21 %, p = 0.004), and to have been on HAART for less time (61 [IQR 35, 108] vs 153 weeks [IQR 63, 298]; p < 0.001). Among all clients, similar proportions of refugee and host clients were <95 % adherent to pharmacy refills (26 vs 34 %, p = 0.15). When restricting to clients on treatment for ≥25 weeks, similar proportions from each group were not virologically suppressed (19 % of refugees vs 16 % of host clients, p = 0.54). Refugee status was not independently associated with the outcome (adjusted odds ratio, aOR = 1.28, 95 % CI 0.52, 3.14). Overall, the proportions of refugee and host community clients with unsuppressed viral loads and sub-optimal adherence were similar, supporting the idea that refugees in protracted asylum situations are able to sustain good treatment outcomes and should explicitly be included in the HIV strategic plans of host countries with a view to expanding access in accordance with national guidelines for HAART.
Appendix
Available only for authorised users
Literature
1.
go back to reference UNAIDS. UNAIDS World AIDS Day Report. Geneva; 2012. UNAIDS. UNAIDS World AIDS Day Report. Geneva; 2012.
2.
go back to reference UN General Assembly. Convention relating to the Status of Refugees. In: Treaty series, vol 189, p 137 United Nations; 1951. UN General Assembly. Convention relating to the Status of Refugees. In: Treaty series, vol 189, p 137 United Nations; 1951.
3.
go back to reference International Federation of Red Cross and Red Crescent Societies. World Disaster Report 2008: Focus on HIV and AIDS. Geneva 2008; p.118–41. International Federation of Red Cross and Red Crescent Societies. World Disaster Report 2008: Focus on HIV and AIDS. Geneva 2008; p.118–41.
4.
go back to reference UNHCR, Southern African HIV Clinicians Society. Clinical guidelines for antiretroviral therapy management for displaced populations. Geneva: UNHCR; 2007. UNHCR, Southern African HIV Clinicians Society. Clinical guidelines for antiretroviral therapy management for displaced populations. Geneva: UNHCR; 2007.
5.
go back to reference Trippayya V. Botswana: refugees not entitled to same services as citizens. HIV AIDS Policy Law Rev. 2005;10(3):27–8.PubMed Trippayya V. Botswana: refugees not entitled to same services as citizens. HIV AIDS Policy Law Rev. 2005;10(3):27–8.PubMed
6.
go back to reference Mendelsohn JB, Schilperoord M, Spiegel P, Ross DA. Adherence to antiretroviral therapy and treatment outcomes in conflict-affected and forcibly displaced populations: a systematic review. Confl Health. 2012;6(1):9.PubMedCentralPubMedCrossRef Mendelsohn JB, Schilperoord M, Spiegel P, Ross DA. Adherence to antiretroviral therapy and treatment outcomes in conflict-affected and forcibly displaced populations: a systematic review. Confl Health. 2012;6(1):9.PubMedCentralPubMedCrossRef
8.
go back to reference Ministry of Health Malaysia. National Strategic Plan on HIV/AIDS 2006–2010. Kuala Lumpur; 2006. Ministry of Health Malaysia. National Strategic Plan on HIV/AIDS 2006–2010. Kuala Lumpur; 2006.
9.
go back to reference Ministry of Health Malaysia. National Strategic Plan on HIV/AIDS 2011–2015. Kuala Lumpur; 2011. Ministry of Health Malaysia. National Strategic Plan on HIV/AIDS 2011–2015. Kuala Lumpur; 2011.
10.
go back to reference Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments. AIDS Care. 2000;12(3):255–66.PubMedCrossRef Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments. AIDS Care. 2000;12(3):255–66.PubMedCrossRef
11.
go back to reference Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef
12.
13.
14.
15.
go back to reference Kaufman JS, Maclehose RF, Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov. 2004;1(1):4.PubMedCentralPubMedCrossRef Kaufman JS, Maclehose RF, Kaufman S. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Epidemiol Perspect Innov. 2004;1(1):4.PubMedCentralPubMedCrossRef
16.
go back to reference Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, et al. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010;11(8):519–29.PubMedCentralPubMed Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, et al. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010;11(8):519–29.PubMedCentralPubMed
17.
go back to reference McCarthy K, Chersich MF, Vearey J, Meyer-Rath G, Jaffer A, Simpwalo S, et al. Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa. Int J STD AIDS. 2009;20:858–62.PubMedCrossRef McCarthy K, Chersich MF, Vearey J, Meyer-Rath G, Jaffer A, Simpwalo S, et al. Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa. Int J STD AIDS. 2009;20:858–62.PubMedCrossRef
18.
go back to reference Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, et al. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS. 2008;22(18):2493–9.PubMedCrossRef Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, et al. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS. 2008;22(18):2493–9.PubMedCrossRef
19.
go back to reference Garang PG, Odoi RA, Kalyango JN. Adherence to antiretroviral therapy in conflict areas: a study among patients receiving treatment from Lacor Hospital, Uganda. AIDS Patient Care STDS. 2009;23(9):743–7.PubMedCrossRef Garang PG, Odoi RA, Kalyango JN. Adherence to antiretroviral therapy in conflict areas: a study among patients receiving treatment from Lacor Hospital, Uganda. AIDS Patient Care STDS. 2009;23(9):743–7.PubMedCrossRef
20.
go back to reference Salami O, Buzu A, Nzeme C. High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan. J Int AIDS Soc. 2010;13(Supp l4):123.CrossRef Salami O, Buzu A, Nzeme C. High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan. J Int AIDS Soc. 2010;13(Supp l4):123.CrossRef
21.
go back to reference Culbert H, Tu D, O’Brien DP, Ellman T, Mills C, Ford N, et al. HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med. 2007;4(5):e129.PubMedCentralPubMedCrossRef Culbert H, Tu D, O’Brien DP, Ellman T, Mills C, Ford N, et al. HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med. 2007;4(5):e129.PubMedCentralPubMedCrossRef
22.
go back to reference Lima V, Fernandes K, Rachlis B, Druyts E, Montaner J, Hogg R. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med. 2009;68(6):1044–9.PubMedCrossRef Lima V, Fernandes K, Rachlis B, Druyts E, Montaner J, Hogg R. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med. 2009;68(6):1044–9.PubMedCrossRef
23.
go back to reference Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One. 2010;5(5):e10584.PubMedCentralPubMedCrossRef Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One. 2010;5(5):e10584.PubMedCentralPubMedCrossRef
24.
go back to reference Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88(9):681–8.PubMedCentralPubMedCrossRef Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88(9):681–8.PubMedCentralPubMedCrossRef
25.
go back to reference Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547.PubMedCentralPubMedCrossRef Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5):e35547.PubMedCentralPubMedCrossRef
26.
go back to reference Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.PubMedCentralPubMedCrossRef Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.PubMedCentralPubMedCrossRef
27.
go back to reference Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10(5):483–93.PubMedCrossRef Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10(5):483–93.PubMedCrossRef
28.
go back to reference Cornell M, Myer L, Kaplan R, Bekker LG, Wood R. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health. 2009;14(7):722–31.PubMedCentralPubMedCrossRef Cornell M, Myer L, Kaplan R, Bekker LG, Wood R. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health. 2009;14(7):722–31.PubMedCentralPubMedCrossRef
29.
go back to reference Dou Z, Xu J, Jiao JH, Ma Y, Durako S, Yu L, et al. Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006–2008. PLoS ONE. 2011;6(8):e22707.PubMedCentralPubMedCrossRef Dou Z, Xu J, Jiao JH, Ma Y, Durako S, Yu L, et al. Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006–2008. PLoS ONE. 2011;6(8):e22707.PubMedCentralPubMedCrossRef
30.
go back to reference Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu. South Africa. S Afr Med J. 2006;96(4):315–20. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu. South Africa. S Afr Med J. 2006;96(4):315–20.
31.
go back to reference Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5(5):e109.PubMedCentralPubMedCrossRef Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5(5):e109.PubMedCentralPubMedCrossRef
32.
go back to reference Grossberg R, Zhang YW, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–10.PubMedCrossRef Grossberg R, Zhang YW, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–10.PubMedCrossRef
33.
go back to reference Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons With HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons With HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef
34.
go back to reference Spiegel PB, Checchi F, Colombo S, Paik E. Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet. 2010;375(9711):341–5.PubMedCrossRef Spiegel PB, Checchi F, Colombo S, Paik E. Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet. 2010;375(9711):341–5.PubMedCrossRef
35.
go back to reference Dahab M, Charalambous S, Karstaedt AS, Fielding KL, Hamilton R, La Grange L, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. BMC Public Health. 2010;10:430.PubMedCentralPubMedCrossRef Dahab M, Charalambous S, Karstaedt AS, Fielding KL, Hamilton R, La Grange L, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. BMC Public Health. 2010;10:430.PubMedCentralPubMedCrossRef
36.
go back to reference Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756. Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756.
37.
go back to reference Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.PubMedCrossRef Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.PubMedCrossRef
38.
go back to reference Yusof ZA, Bhattasali D. Economic growth and development in Malaysia: policy making and leadership (Working paper no. 27). Washington DC: Commission on Growth and Development; 2008. Yusof ZA, Bhattasali D. Economic growth and development in Malaysia: policy making and leadership (Working paper no. 27). Washington DC: Commission on Growth and Development; 2008.
39.
go back to reference Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, Agins B. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquired Immune Defic Syndr. 2003;33(4):484–93.CrossRef Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, Agins B. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquired Immune Defic Syndr. 2003;33(4):484–93.CrossRef
40.
go back to reference Zhang S, van Sighem A, Gras L, Reiss P, Smit C, Kroon F, et al. Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment. Antivir Ther. 2010;15(4):555–62.PubMedCrossRef Zhang S, van Sighem A, Gras L, Reiss P, Smit C, Kroon F, et al. Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment. Antivir Ther. 2010;15(4):555–62.PubMedCrossRef
41.
go back to reference Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, et al. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA. 2005;293(7):817–29.PubMedCrossRef Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, et al. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA. 2005;293(7):817–29.PubMedCrossRef
42.
go back to reference Fung IC, Gambhir M, van Sighem A, de Wolf F, Garnett GP. The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence? J Acquired Immune Defic Syndr. 2012;60(1):5–11.CrossRef Fung IC, Gambhir M, van Sighem A, de Wolf F, Garnett GP. The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence? J Acquired Immune Defic Syndr. 2012;60(1):5–11.CrossRef
43.
go back to reference Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, et al. Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. J Infect Dis. 2012;205(8):1230–8.PubMedCrossRef Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, et al. Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. J Infect Dis. 2012;205(8):1230–8.PubMedCrossRef
Metadata
Title
Is Forced Migration a Barrier to Treatment Success? Similar HIV Treatment Outcomes Among Refugees and a Surrounding Host Community in Kuala Lumpur, Malaysia
Authors
Joshua B. Mendelsohn
Marian Schilperoord
Paul Spiegel
Susheela Balasundaram
Anuradha Radhakrishnan
Christopher K. C. Lee
Natasha Larke
Alison D. Grant
Egbert Sondorp
David A. Ross
Publication date
01-02-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0494-0

Other articles of this Issue 2/2014

AIDS and Behavior 2/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.